Cleared Special

PuraStat

K253924 · 3-D Matrix Europe SAS · General & Plastic Surgery
Jan 2026
Decision
30d
Days
Class 2
Risk

About This 510(k) Submission

K253924 is an FDA 510(k) clearance for the PuraStat, a Hemostatic Device For Endoscopic Gastrointestinal Use (Class II — Special Controls, product code QAU), submitted by 3-D Matrix Europe SAS (Caluire Et Cuire, FR). The FDA issued a Cleared decision on January 7, 2026, 30 days after receiving the submission on December 8, 2025. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4456.

Submission Details

510(k) Number K253924 FDA.gov
FDA Decision Cleared SESE
Date Received December 08, 2025
Decision Date January 07, 2026
Days to Decision 30 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QAU — Hemostatic Device For Endoscopic Gastrointestinal Use
Device Class Class II — Special Controls
CFR Regulation 21 CFR 878.4456
Definition Hemostatic Device For Intraluminal Gastrointestinal Use. A Hemostatic Device For Intraluminal Gastrointestinal Use Is A Prescription Device That Is Endoscopically Applied To The Upper And/or Lower Gastrointestinal Tract And Is Intended To Produce Hemostasis Via Absorption Of Fluid Or By Other Physical Means.